How to measure biomechanical properties today

Article

The primary function of biomechanical measurements is to improve safety and doctors can readily use these metrics in clinical practice today through the use of proxies, said William J. Dupps, MD.

The primary function of biomechanical measurements is to improve safety and doctors can readily use these metrics in clinical practice today through the use of proxies, said William J. Dupps, MD.

"Readily-measured variables that share some relationship to a biomechanical property of interest include central corneal thickness (CCT), corneal topography, or 'warpability', residual stromal thickness (RST) and time, which is useful to measure warpage recovery time," said Dr Dupps of the Cole Eye Institute, Cleveland, USA.

The advantage of proxies is that they can provide a rational, predictive variable for the safety of a given procedure, they are accessible and usually routine and population norms are well established.

He did, however, caution that there are problems using proxies. They are incomplete representations, they can be confounded by other uncontrollable or unmeasured variables and they can be insensitive to early disease.

Dr Dupps also reviewed the Ocular Response Analyser (ORA), which provides corneal hysteresis (CH) and corneal resistance factor (CRF) metrics, which provide keratoconic signals.

"While we are currently only using the corneal hysteresis value, clearly there is additional valuable information present in the shape of the measurement signal," he said.

Dr Dupps concluded by outlining tomorrow's challenges, among which are the need for a quantitative analysis of ORA signal morphology and to establish a conservative reference population as well as a "safe range" of CH, CRF and emergent variables.

Dr Dupps advised that the November issue of the Journal of Cataract and Refractive Surgery will report on advances in anatomic measurement.

Ophthalmology Times Europe reporting from the XXIV Congress of the ESCRS, London, 9-13 September, 2006.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.